Sildenafil Citrate NDC 72789-405

Product information

Brand name (proprietary)

Sildenafil Citrate

Generic name (nonproprietary)

sildenafil citrate

Active ingredients

Sildenafil citrate — 50 mg/1

Dosage form

Tablet

Route

Oral

Labeler

PD-Rx Pharmaceuticals, Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 209302

Marketing start

Sep 4, 2020

Listing expires

Dec 31, 2026

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 72789-405_31f6c2bb-9a5b-e2f0-e063-6294a90aace5SPL ID 31f6c2bb-9a5b-e2f0-e063-6294a90aace5SPL set ID dc4430cc-8238-4d6d-99ff-bbb9d0b51bd1RxCUI 312950UNII BW9B0ZE037UPC 0372789405308

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472789040515 followed by a unit qualifier and the quantity Copy

Package 72789-0405-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 209302

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.